Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 18.58 billion as of February 28, 2025. Its market cap has increased by 125.27% in one year.

Market Cap

18.58B

Enterprise Value

19.48B

Revenue

40.96M

Ranking

n/a

PE Ratio

n/a

Stock Price

78.00

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has increased from 16.77B to 18.58B, an increase of 10.77%. That is a compound annual growth rate of 1.08%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2025	18.58B	73.65%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	9.89B	-9.41%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition